English
This Project is not specific to Greece. For more details, please visit OpenAIRE Explore.
Link with research outputs.
Please log in first and try again.
BINGO-2 (Biliary cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin): A randomized phase III trial assessing the activity of gemcitabine-oxaliplatin chemotherapy alone or in combination with cetuximab in patients with advanced biliary cancer
FunderInstitut National du Cancer
Funded underPHRC
Call for proposalPHRC11
Project codeINCa-DGOS-3830
Open Access mandatePublications: NoResearch data: No
Identifiers
Description
N/A
Partners (19)
Start a new DMP in Loading
